SPPH Stock Chart & Stats
$0.14
$0.00(0.00%)
At close: 4:00 PM EDT
$0.14
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.14 - $0.14
Previous CloseN/A
Volume3.00K
Average Volume (3M)0.00
Market Cap
$294.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding294,363,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SPPH FAQ
What was Spencer Pharmaceutical’s price range in the past 12 months?
Spencer Pharmaceutical lowest stock price was $0.14 and its highest was $0.14 in the past 12 months.
What is Spencer Pharmaceutical’s market cap?
Spencer Pharmaceutical’s market cap is $294.00.
When is Spencer Pharmaceutical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Spencer Pharmaceutical’s earnings last quarter?
Currently, no data Available
Is Spencer Pharmaceutical overvalued?
According to Wall Street analysts Spencer Pharmaceutical’s price is currently Overvalued.
Does Spencer Pharmaceutical pay dividends?
Spencer Pharmaceutical does not currently pay dividends.
What is Spencer Pharmaceutical’s EPS estimate?
Spencer Pharmaceutical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Spencer Pharmaceutical have?
Spencer Pharmaceutical has 294,363,000 shares outstanding.
What happened to Spencer Pharmaceutical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Spencer Pharmaceutical?
Currently, no hedge funds are holding shares in SPPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Spencer Pharmaceutical
Spencer Pharmaceutical Inc. is dedicated to pioneering drug delivery platforms aimed at addressing neurological conditions. A core aspect of their expertise lies in the precise, controlled administration of existing therapeutic compounds for central nervous system disorders, such as Alzheimer's, Parkinson's disease, and various forms of brain cancer. Moreover, the company holds a proprietary slow-release drug delivery system, which is utilized for managing type-2 diabetes and arthritis, and holds promise for other medical applications. Its operations are predominantly located in North America and Europe. Spencer Pharmaceutical Inc. was established in 1998 and maintains its headquarters in Boston, Massachusetts.
Technical Analysis
Biodexa Pharmaceuticals
―
Nuwellis
―
Oragenics
―
Rein Therapeutics
―
Neuphoria Therapeutics
―